193 related articles for article (PubMed ID: 32810829)
1. GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma.
Negroni C; Hilton DA; Ercolano E; Adams CL; Kurian KM; Baiz D; Hanemann CO
EBioMedicine; 2020 Sep; 59():102941. PubMed ID: 32810829
[TBL] [Abstract][Full Text] [Related]
2. miR-497 and 219 in blood aid meningioma classification.
Abdelrahman A; Negroni C; Sahm F; Adams CL; Urbanic-Purkart T; Khalil M; Vergura R; Morelli C; Hanemann CO
J Neurooncol; 2022 Oct; 160(1):137-147. PubMed ID: 36076132
[TBL] [Abstract][Full Text] [Related]
3. A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma.
Zhi F; Shao N; Li B; Xue L; Deng D; Xu Y; Lan Q; Peng Y; Yang Y
Sci Rep; 2016 Aug; 6():32067. PubMed ID: 27558167
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Downregulation of Hsa-miR-193b-3p Increases Cyclin D1 Expression Level and Cell Proliferation in Human Meningiomas.
Kober P; Mossakowska BJ; Rusetska N; Baluszek S; Grecka E; Konopiński R; Matyja E; Oziębło A; Mandat T; Bujko M
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686289
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
[TBL] [Abstract][Full Text] [Related]
7. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
8. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
10. Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas.
Sofela AA; Hilton DA; Ammoun S; Baiz D; Adams CL; Ercolano E; Jenkinson MD; Kurian KM; Teo M; Whitfield PC; Sahm F; Hanemann CO
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33429944
[TBL] [Abstract][Full Text] [Related]
11. Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs.
Ludwig N; Kim YJ; Mueller SC; Backes C; Werner TV; Galata V; Sartorius E; Bohle RM; Keller A; Meese E
Neuro Oncol; 2015 Sep; 17(9):1250-60. PubMed ID: 25681310
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous analysis of miRNA-mRNA in human meningiomas by integrating transcriptome: A relationship between PTX3 and miR-29c.
Dalan AB; Gulluoglu S; Tuysuz EC; Kuskucu A; Yaltirik CK; Ozturk O; Ture U; Bayrak OF
BMC Cancer; 2017 Mar; 17(1):207. PubMed ID: 28327132
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
[TBL] [Abstract][Full Text] [Related]
14. MiR-34a-3p alters proliferation and apoptosis of meningioma cells
Werner TV; Hart M; Nickels R; Kim YJ; Menger MD; Bohle RM; Keller A; Ludwig N; Meese E
Aging (Albany NY); 2017 Mar; 9(3):932-954. PubMed ID: 28340489
[TBL] [Abstract][Full Text] [Related]
15. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells.
Kliese N; Gobrecht P; Pachow D; Andrae N; Wilisch-Neumann A; Kirches E; Riek-Burchardt M; Angenstein F; Reifenberger G; Riemenschneider MJ; Meese E; Panayotova-Dimitrova D; Gutmann DH; Mawrin C
Oncogene; 2013 Sep; 32(39):4712-20. PubMed ID: 23108408
[TBL] [Abstract][Full Text] [Related]
16. A microRNA expression signature predicts meningioma recurrence.
Zhi F; Zhou G; Wang S; Shi Y; Peng Y; Shao N; Guan W; Qu H; Zhang Y; Wang Q; Yang C; Wang R; Wu S; Xia X; Yang Y
Int J Cancer; 2013 Jan; 132(1):128-36. PubMed ID: 22674195
[TBL] [Abstract][Full Text] [Related]
17. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive overview of extracellular vesicle proteomics in meningioma: future strategy.
Rana R; Sharma S; Ganguly NK
Mol Biol Rep; 2021 Dec; 48(12):8061-8074. PubMed ID: 34687392
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-195 Functions as a Tumor Suppressor by Directly Targeting Fatty Acid Synthase in Malignant Meningioma.
Song LR; Li D; Weng JC; Li CB; Wang L; Wu Z; Zhang JT
World Neurosurg; 2020 Apr; 136():e355-e364. PubMed ID: 31927122
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-224 targets ERG2 and contributes to malignant progressions of meningioma.
Wang M; Deng X; Ying Q; Jin T; Li M; Liang C
Biochem Biophys Res Commun; 2015 May; 460(2):354-61. PubMed ID: 25783051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
